/  H.R. 2851—Stop the Importation and Trafficking of Synthetic Analogues Act of 2017

H.R. 2851 - Stop the Importation and Trafficking of Synthetic Analogues Act of 2017

Bill Text

  • Rules Committee Print 115-74 PDF XML

    Showing the text of H.R. 2851 as ordered reported by the Committee on the Judiciary.

  • Text of H.R. 2851 PDF XML

    Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (as introduced).

  • H. Rept. 115-713, Part I PDF

    Report from the Committee on the Judiciary

Rule Information

COMMITTEE ACTION:
REPORTED BY RECORD VOTE of 7-4 on Tuesday, June 12, 2018.

FLOOR ACTION ON H. RES. 934: 
Agreed to by record vote of 233-175, after agreeing to the previous questions by record vote of 230-183 on Wednesday, June 13, 2018.  

MANAGERS: Buck/Polis

1. Structured rule for H.R. 2851.

2. Provides one hour of general debate equally divided and controlled by the chair and ranking minority member of the Committee on the Judiciary.

3. Waives all points of order against consideration of the bill.

4. Makes in order as original text for the purpose of amendment an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-74 and provides that it shall be considered as read.

5. Waives all points of order against that amendment in the nature of a substitute.

6. Makes in order only those further amendments printed in part A of the Rules Committee report. Each such amendment may be offered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, shall not be subject to amendment, and shall not be subject to a demand for division of the question.

7. Waives all points of order against the amendments printed in part A of the report.

8. Provides one motion to recommit with or without instructions.

9. Structured rule for H.R. 5735.

10. Provides one hour of general debate equally divided and controlled by the chair and ranking minority member of the Committee on Financial Services.

11. Waives all points of order against consideration of the bill.

12. Makes in order as original text for the purpose of amendment an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-73 and provides that it shall be considered as read.

13. Waives all points of order against that amendment in the nature of a substitute.

14. Makes in order only those further amendments printed in part B of the Rules Committee report. Each such amendment may be offered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, shall not be subject to amendment, and shall not be subject to a demand for division of the question.

15. Waives all points of order against the amendments printed in part B of the report.

16. Provides one motion to recommit with or without instructions.

17. Closed rule for H.R. 5788.

18. Provides one hour of debate equally divided and controlled by the chair and ranking minority member of the Committee on Ways and Means.

19. Waives all points of order against consideration of the bill.

20. Provides that the amendment printed in part C of the Rules Committee report, modified by the amendment printed in part D of the report, shall be considered as adopted and the bill, as amended, shall be considered as read.

21. Waives all points of order against provisions in the bill, as amended.

22. Provides one motion to recommit with or without instructions.

Amendments (click headers to sort)

#Version #Sponsor(s)PartySummaryStatus
14Version 1Adams (NC)DemocratLate Requires the Attorney General to consult the American Chemical Society and International Union of Pure and Applied Chemistry when making determinations of drug equivalencies. Submitted
15Version 2Adams (NC)DemocratLate Revised Requires the Attorney General to consider the conclusions of a Section 201(b) analysis conducted by the Secretary of HHS in any scheduling determination.Submitted
11Version 1Biggs (AZ)RepublicanRemoves the AG’s authority to permanently schedule a substance on Schedule A; requires an imminent hazard to public safety for scheduling temporarily; and limits the temporary scheduling authority to 2 years instead of 5.Submitted
8Version 1Connolly (VA)DemocratRestores the Drug Enforcement Agency’s authority to suspend a pharmaceutical distributor’s license to stop suspicious shipments of prescription drugs.Submitted
1Version 2Griffith (VA), Raskin (MD), Jackson Lee (TX)Bi-PartisanRevised Incorporates an inter-agency agreement transmitted to Congress by the Office of National Drug Control Policy (ONDCP), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ). Specifically, the amendment clarifies when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A and prevents the Attorney General from permanently scheduling that drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse. The amendment also clarifies under what circumstances an applicant for a schedule A registration may continue to conduct research with such schedule A substance while their application is pending, among their research accommodations.Made In Order
4Version 1Jackson Lee (TX)DemocratStrikes sentencing commission provision. Made In Order
5Version 1Jackson Lee (TX)DemocratCriminalizes managers and leaders of criminal activitySubmitted
9Version 1Jackson Lee (TX)DemocratEnsures penalties for schedule A controlled substance may not be ordered to run consecutively.Submitted
16Version 2Jackson Lee (TX)DemocratLate Revised Strikes mandatory minimum terms of supervised releaseSubmitted
12Version 1Keating (MA)DemocratLate Repeals Public Law 114–145, which compromised the ability of the DEA to swiftly act to combat unsafe opioid distribution.Submitted
6Version 2Maloney, Sean (NY)DemocratRevised Requires the Drug Enforcement Administration to make available a report on controlled substance analogues sold by means of the internet. Made In Order
2Version 1Norcross (NJ)DemocratRequires 30% of funds collected from fines in this bill are authorized to go towards the Bureau of Justice Assistance’s Residential Substance Abuse Treatment for State Prisoners Program.Submitted
3Version 1Norcross (NJ)DemocratRequires 30% of funds collected from fines in this bill are authorized to go towards substance use disorder treatment programs within the federal Bureau of Prisons.Submitted
10Version 1Pocan (WI), Gosar (AZ), Polis (CO)Bi-PartisanPrevents the Secretary from placing a natural botanical substance under new Scheduling authority, and would require Secretary to use existing scheduling proceedings under the Controlled Substances Act, if supported by existing medical and scientific facts. Submitted
7Version 1Polis (CO), Correa (CA)DemocratRequires the VA to study medicinal marijuana as an alternative treatment option to prescription opioids. Submitted
13Version 1Thornberry (TX)RepublicanLate Specifies the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers.Made In Order